3 completed, 2 not yet recruiting, 2 recruiting, 1 unknown. 7 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Completed 2, Not yet recruiting 2, Recruiting 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow SmartNuclide Biopharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33 GPA33-CC；177Lu-SmartD2 - Colorectal Cancer | Early Phase 1 | Not yet recruiting | SmartNuclide Biopharma | 20 | 2026-05-01 | 2026-05-15 |
| A IIT Study of 177Lu-DOTA-SNA040 177Lu-DOTA-SNA040 - Advanced Solid Tumors (Such as Gastric Cancer), Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction) | Early Phase 1 | Recruiting | SmartNuclide Biopharma | 12 | 2025-11-01 | 2026-08-21 |
| Phase IIT Trial of SNA009 68Ga-NODAGA-SNA009 - Colorectal Cancer, GPA33 | Early Phase 1 | Completed | SmartNuclide Biopharma | 12 | 2025-10-30 | 2026-05-19 |
| Preliminary Trial of SNA014 for Pancreatic Cancer 68Ga-NODAGA-SNA006 - Pancreatic Cancer | Early Phase 1 | Recruiting | SmartNuclide Biopharma | 12 | 2025-10-01 | 2026-05-19 |
| Phase IIT Trial of SNA014 [68Ga]Ga-NODAGA-SNA014 - Adenocarcinoma of the Stomach, Adenocarcinoma of GE Junction | Early Phase 1 | Not yet recruiting | SmartNuclide Biopharma | 28 | 2024-10-20 | 2024-10-17 |
| Phase I Clinical Trial of 68Ga-NOTA-SNA002 68Ga-NOTA-SNA002 - Solid Tumor, Positron-Emission Tomography(PET) | Phase 1 | Completed | SmartNuclide Biopharma | 17 | 2023-11-01 | 2025-09-16 |
| [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors [68Ga]Ga-NOTA-SNA002 - Solid Tumor, Positron-Emission Tomography(PET) | Early Phase 1 | Unknown | SmartNuclide Biopharma | 20 | 2022-10-18 | 2023-12-07 |
| A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors 68Ga-NODAGA-SNA006 - Solid Tumor | Early Phase 1 | Completed | SmartNuclide Biopharma | 11 | 2021-11-02 | 2023-04-12 |
Colorectal Neoplasms (2) · Pancreatic Neoplasms (1)
Magnetic Resonance Spectroscopy (1)
China (8)
Liyan Miao, Ph.D (2) · Songbing Qin (2) · Hongcheng Shi, Doctor (1)